ConductScience.org, home

Paper · 66280

Effects of carrageenan on immune responses. Studies on the macrophage dependency of various antigens after treatment with carrageenan.

Ishizaka S and 2 others. J Immunol, 1977. Cited by 85 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of carrageenan on immune responses. Studies on the macrophage dependency of various antigens after treatment with carrageenan. Papers, record 66280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/66280

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of carrageenan on immune responses. Studies on the macrophage dependency of various antigens after treatment with carrageenan.
PubMed
Journal
J Immunol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
2.47
iCite
Revised in PubMed
2017-11-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ishizaka SS
2Otani SS
3Morisawa SS

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
AntigensMajor topic
CarrageenanMajor topic
MacrophagesMajor topic
Animals
Concanavalin A
Erythrocytes
Ficoll
In Vitro Techniques
Kinetics
Lectins
Lipopolysaccharides
Male
Mice
Mice, Inbred AKR
Mice, Inbred C3H
Povidone
Spleen
T-Lymphocytes
gamma-Globulins

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
7,020,378Carrageenan: a review of its effects on the immune system.Agents Actions1981https://conductscience.org/library/papers/7020378PubMed
7,007,221BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.Immunology1981https://conductscience.org/library/papers/7007221PubMed
7,002,771Accessory cell function in immune responses in vivo: enhancing effect of radioresistant spleen cells on antibody response to SRBC in rats.Immunology1980https://conductscience.org/library/papers/7002771PubMed
6,969,217Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.Immunology1980https://conductscience.org/library/papers/6969217PubMed
6,721,577Effect of macrophages on elimination of dermal melanin from the dermis.Arch Dermatol Res1984https://conductscience.org/library/papers/6721577PubMed
6,609,120Follicular trapping of hapten-erythrocyte-antibody complexes in mouse spleen.Immunology1984https://conductscience.org/library/papers/6609120PubMed
6,448,801Active suppression masks an underlying enhancement of antibody production in vitro by spleen cells from BCG-infected mice.Immunology1980https://conductscience.org/library/papers/6448801PubMed
6,245,672Selective macrophage inhibition abolishes warfarin-induced reduction of metastasis.Br J Cancer1980https://conductscience.org/library/papers/6245672PubMed
6,237,983Macrophage-mediated suppression of T lymphocyte proliferation induced by oral carrageenan administration.Immunology1984https://conductscience.org/library/papers/6237983PubMed
3,698,367Restoration by recombinant interferon alpha A/D of host defense systems against tumor in immunosuppressed mice.Clin Exp Metastasis1986https://conductscience.org/library/papers/3698367PubMed

1 to 10 of 14

See all 14 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/66280

GET https://conductscience.org/api/papers/v1/66280/authors